Kulik A, Lam B-K, Rubens F D, Hendry P J, Masters R G, Goldstein W, Bédard P, Mesana T G, Ruel M
University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, Canada.
Heart. 2009 Feb;95(4):318-26. doi: 10.1136/hrt.2008.146688. Epub 2008 Jul 24.
To compare the long-term outcomes in women and men after valve replacement surgery.
Observational study.
Postoperative aortic valve replacement (AVR) or mitral valve replacement (MVR).
3118 patients (1261 women, 1857 men) who underwent AVR or MVR between 1976 and 2006 (2255 AVR, 863 MVR), with mean follow-up of 5.6 (4.5) years.
The independent effect of gender on the risk of long-term complications (reoperation, stroke and death) after valve replacement surgery using multivariate actuarial methods.
After implantation of an aortic valve bioprosthesis, women had a significantly lower rate of reoperation compared to men (comorbidity-adjusted hazard ratio (HR) 0.4; 95% confidence intervals (CI) 0.2 to 0.9). In contrast, if an aortic mechanical prosthesis had been implanted, women were more at risk for late stroke compared to men (HR 1.7; CI 1.1 to 2.7). After adjustment for age and co-morbidities, women had significantly better long-term survival compared to men after bioprosthetic AVR (HR 0.5; CI 0.3 to 0.6), but there was no survival difference between genders after mechanical AVR. Trends existed towards better survival for women after bioprosthetic MVR (HR 0.6; CI 0.4 to 1.0) and mechanical MVR (HR 0.8; CI 0.5 to 1.1).
The long-term outcomes after valve replacement surgery differ between women and men. Although women have more late strokes after valve replacement, they undergo fewer reoperations and have better overall long-term survival compared to men.
比较瓣膜置换术后女性和男性的长期预后。
观察性研究。
主动脉瓣置换术(AVR)或二尖瓣置换术(MVR)术后。
1976年至2006年间接受AVR或MVR的3118例患者(1261例女性,1857例男性)(2255例AVR,863例MVR),平均随访5.6(4.5)年。
采用多变量精算方法评估性别对瓣膜置换术后长期并发症(再次手术、中风和死亡)风险的独立影响。
植入主动脉生物瓣膜后,女性再次手术率显著低于男性(合并症调整风险比(HR)0.4;95%置信区间(CI)0.2至0.9)。相反,如果植入主动脉机械瓣膜,女性晚期中风风险高于男性(HR 1.7;CI 1.1至2.7)。调整年龄和合并症后,生物瓣膜AVR术后女性长期生存率显著高于男性(HR 0.5;CI 0.3至0.6),但机械瓣膜AVR术后两性生存率无差异。生物瓣膜MVR(HR 0.6;CI 0.4至1.0)和机械瓣膜MVR(HR 0.8;CI 0.5至1.1)术后女性生存率有改善趋势。
瓣膜置换术后女性和男性的长期预后不同。尽管女性瓣膜置换术后晚期中风较多,但与男性相比,她们再次手术较少,总体长期生存率更高。